Scientific ReportsGenetic & Genomic MedicinePeer-reviewed journal article
Targeted gene expression profiling for accurate endometrial receptivity testing
Alvin MeltsoviD, Merli SaareiD, Hindrek TederiD, Priit PaluojaiD, Riikka K. ArffmaniD, Terhi PiltoneniD, Piotr LaudańskiiD, Mirosław WielgośiD, Luca GianaroliiD, Mariann KoeliD, Maire PetersiD, Andres SalumetsiD, Kaarel KrjutškoviD, Priit PaltaiD
Abstract
STUDY QUESTIONHow accurately can a targeted gene expression sequencing assay estimate endometrial receptivity corresponding to the window of implantation? DESIGNEndometrial biopsies (n=175) from healthy fertile volunteers (n=66), polycystic ovarian syndrome (PCOS) patients (n=39), and recurrent implantation failure (RIF) patients (n=44) were collected and sequenced with TAC-seq (Targeted Allele Counting by sequencing) method targeting 68 biomarker genes for endometrial receptivity. The expressional profiles were clustered, and differential expression analysis was performed on the model development group, using 63 endometrial biopsies spanning over proliferative (PE, n=18), early-secretory (ESE, n=18), mid-secretory (MSE, n=17) and late-secretory (LSE, n=10) endometrial phases. A quantitative predictor model was trained on the development group and validated on sequenced samples from healthy women, consisting of 52 paired samples taken from ESE and MSE phases and five LSE phase samples from 31 individuals. Finally, the developed test was applied to 44 MSE phase samples gathered from a study group of patients diagnosed with RIF. RESULTSThe developed assay successfully captures the unique receptivity profile of the endometrium using 68 biomarker genes. When compared to healthy women of the same cycle phase, we did not detect any significant gene expression bias caused by PCOS in PE, ESE, MSE, and LSE samples. In validation samples (n=57), we detected displaced WOI in 1.8% of the samples from fertile women. In the RIF study group, we detected a significantly higher proportion of the samples with shifted WOI than in the validation set of samples from fertile women, 15.9% and 1.8%, respectively. CONCLUSIONSThe developed beREADY screening test enables highly sensitive and dynamic detection of selected transcriptome biomarkers, providing a quantitative and accurate prediction of endometrial receptivity status for personalised embryo transfer.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 38
- FWCI
- 4.04
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Human Endometrial Transcriptome and Progesterone Receptor Cistrome Reveal Important Pathways and Epithelial Regulators
Alicia Chi, Tianyuan Wang, … Francesco John DeMayo·The Journal of Clinical Endocrinology & MetabolismPeer-reviewed·Oct 29, 2019
- EndoTwin-W: glycodelin-A and CA-125 as non-invasive biomarkers of endometrial receptivity derived from a multiscale computational digital twin
Ravi Goyal·bioRxiv·Jun 2, 2026
- Dynamic Changes in Endometrial Folding and Secretory Activity Across the Menstrual Cycle
Jessica Garcia de Paredes, Anat Chemerinski, … Ripla Arora·bioRxiv·Sep 28, 2026
- Single cell mapping of the human endometrium and first trimester decidua identifies distinct epithelial and stromal cell contributions to fertility
Gregory W. Burns, Emmanuel N. Paul, … Nataki C. Douglas·JCI InsightPeer-reviewed·Jan 22, 2026
- Human receptive endometrial assembloid for deciphering the implantation window
- Endometrial transcriptomic and ciliation analysis after scratch shows no signature linked to live birth following IVF
Ella Proudley, Jane K. Cleal, … Ying C Cheong·bioRxiv·Jul 23, 2026